I'm going to just say it bluntly, if I can. It almost seems that the pharmaceutical industry—which controls where the R and D goes, where they launch drugs and where they have their clinical trials—is threatening to reduce these things in Canada if the government proceeds with regulatory changes that are geared towards reducing prices that Canadians pay for increasingly expensive prescription drugs, getting our prices more in line with what other countries are paying, and making some changes to improve the pricing process.
Would that be a fair comment?